Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04179864
Title A Phase 1b/2 Open-Label Study in Chemotherapy Naive Subjects With Metastatic Castration-Resistant Prostate Cancer
Acronym CELLO-1
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Epizyme, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | BEL


No variant requirements are available.